Slashdot Mirror
Why Geim Never Patented Graphene
gbrumfiel writes "As we discussed on Tuesday, Andre Geim won this year's Nobel prize in physics for graphene, but he never patented it. In an interview with Nature News, he explains why: 'We considered patenting; we prepared a patent and it was nearly filed. Then I had an interaction with a big, multinational electronics company. I approached a guy at a conference and said, "We've got this patent coming up, would you be interested in sponsoring it over the years?" It's quite expensive to keep a patent alive for 20 years. The guy told me, "We are looking at graphene, and it might have a future in the long term. If after ten years we find it's really as good as it promises, we will put a hundred patent lawyers on it to write a hundred patents a day, and you will spend the rest of your life, and the gross domestic product of your little island, suing us." That's a direct quote.'"
That's how patents work in biotech. First you find a gene, then you immediately patent it - don't worry about figureing out what it does, because if you delay to do that a competitor might file first. Then you figure out what it does, and then you patent every possible application just to be safe. Commercial biotech research is basically driven by patents, but it can get extremally aggressive.